NDAORALTABLET, EXTENDED RELEASE
Approved
Dec 2016
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Sodium-Glucose Transporter 2 Inhibitors
Pharmacologic Class:
Sodium-Glucose Cotransporter 2 Inhibitor
Loss of Exclusivity
LOE Date
Dec 11, 2034
106 months away
Patent Expiry
Dec 11, 2034
Exclusivity Expiry
Dec 20, 2026
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 7713938 | Apr 15, 2027 | SubstanceProduct | — |
| 7713938*PED | Oct 15, 2027 | — | |
| 7579449 | Aug 1, 2028 | Substance | — |
| 7579449*PED | Feb 1, 2029 | — | |
| 12115179 | Feb 11, 2030 | U-4023 |